Related Experiment Video

Updated: Jul 7, 2026

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Inflammation, carotid intima-media thickness and atherosclerosis in rheumatoid arthritis

Jet J C S Veldhuijzen van Zanten, George D Kitas

    Arthritis Research & Therapy
    |January 30, 2008
    PubMed

    Insights

    Carotid intima-media thickness (cIMT) may not reflect permanent atherosclerosis in rheumatoid arthritis patients. Further research is needed to determine if cIMT changes are reversible and if they predict cardiovascular events in this population.

    Area of Science:

    • Cardiovascular disease research
    • Rheumatology
    • Vascular biology

    Background:

    • Carotid intima-media thickness (cIMT) indicates early atherosclerosis and cardiovascular risk in the general population.
    • Increased cIMT is observed in rheumatoid arthritis (RA) patients, suggesting accelerated atherosclerosis, but direct evidence is lacking.
    • The reversibility of cIMT changes based on inflammation intensity in RA is unknown.

    Discussion:

    • High-grade systemic inflammation in RA might cause rapid, reversible cIMT changes, not necessarily structural vessel damage.
    • If cIMT changes are reversible, their predictive value for future cardiovascular events in RA patients may be limited.
    • Current understanding of cIMT in RA needs further investigation to clarify its implications for cardiovascular risk.

    Key Insights:

    • Rheumatoid arthritis patients exhibit increased cIMT, but its direct link to accelerated atherosclerosis requires confirmation.
    • The dynamic nature of cIMT in relation to systemic inflammation intensity in RA remains unelucidated.
    • The prognostic significance of cIMT for cardiovascular events in RA populations is uncertain.

    Outlook:

    • Long-term, prospective studies are essential to determine if cIMT changes in RA are reversible.
    • Further research should investigate the relationship between inflammation, cIMT, and cardiovascular outcomes in rheumatoid arthritis.
    • Clarifying the nature of cIMT in RA is crucial for accurate cardiovascular risk assessment in these patients.

    More Related Videos

    A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology09:33

    A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

    Published on: February 7, 2015

    Related Concept Videos

    Rheumatic Heart Disease I: Introduction01:23

    Rheumatic Heart Disease I: Introduction

    Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
    Atherosclerosis I: Introduction01:30

    Atherosclerosis I: Introduction

    Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

    The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
    Inflammation01:38

    Inflammation

    Overview
    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

    Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...